FERG.UK

16,600

-1.01%↓

MNKS

1,528

+0.92%↑

FERG.UK

16,600

-1.01%↓

MNKS

1,528

+0.92%↑

FERG.UK

16,600

-1.01%↓

MNKS

1,528

+0.92%↑

FERG.UK

16,600

-1.01%↓

MNKS

1,528

+0.92%↑

FERG.UK

16,600

-1.01%↓

MNKS

1,528

+0.92%↑

Search

ConvaTec Group PLC

Open

BrancheFinanzen

247.4 2.57

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

239.2

Max

249

Schlüsselkennzahlen

By Trading Economics

Einkommen

105M

Verkäufe

1.2B

KGV

Branchendurchschnitt

30.375

25.743

EPS

0.08

Dividendenrendite

2.73

Gewinnspanne

8.882

Angestellte

10,000

EBITDA

281M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1941.11% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.73%

3.67%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-238M

4.8B

Vorheriger Eröffnungskurs

244.83

Vorheriger Schlusskurs

247.4

Nachrichtenstimmung

By Acuity

45%

55%

159 / 526 Ranking in Finance

ConvaTec Group PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer-Vergleich

Kursveränderung

ConvaTec Group PLC Prognose

Kursziel

By TipRanks

1941.11% Vorteil

12-Monats-Prognose

Durchschnitt 4,915 GBX  1941.11%

Hoch 32,500 GBX

Tief 270 GBX

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ConvaTec Group PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

8

Buy

0

Halten

0

Sell

Stimmung

By Acuity

159 / 526 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat